Erik Thunnissen

33.5k total citations · 1 hit paper
231 papers, 11.6k citations indexed

About

Erik Thunnissen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Erik Thunnissen has authored 231 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Pulmonary and Respiratory Medicine, 93 papers in Oncology and 49 papers in Molecular Biology. Recurrent topics in Erik Thunnissen's work include Lung Cancer Treatments and Mutations (90 papers), Lung Cancer Diagnosis and Treatment (49 papers) and Cancer Genomics and Diagnostics (39 papers). Erik Thunnissen is often cited by papers focused on Lung Cancer Treatments and Mutations (90 papers), Lung Cancer Diagnosis and Treatment (49 papers) and Cancer Genomics and Diagnostics (39 papers). Erik Thunnissen collaborates with scholars based in Netherlands, United States and United Kingdom. Erik Thunnissen's co-authors include Egbert F. Smit, Serpil C. Erzurum, James E. Boers, Anton W. Ambergen, Giuseppe Giaccone, Daniëlle A.M. Heideman, Neal I. Lindeman, Marc Ladanyi, Jeremy A. Squire and David J. Kwiatkowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Erik Thunnissen

228 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

2013 967 citations Erik Thunnissen et al. profile →

Peers

Countries citing papers authored by Erik Thunnissen

Since Specialization

Citations

This map shows the geographic impact of Erik Thunnissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Thunnissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Thunnissen more than expected).

Fields of papers citing papers by Erik Thunnissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Thunnissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Thunnissen. The network helps show where Erik Thunnissen may publish in the future.

Co-authorship network of co-authors of Erik Thunnissen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Thunnissen. A scholar is included among the top collaborators of Erik Thunnissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Thunnissen. Erik Thunnissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	False positivity in break apart fluorescence in-situ hybridization due to polyploidy 2023 ·Translational Lung Cancer Research ·(unknown), (unknown), (unknown), Mark Kockx, (unknown), Bauke Ylstra, Stephen P. Finn, Lukas Bubendorf, Idris Bahce, Daoud Sie, Teodora Radonic, Birgit I. Lissenberg‐Witte, Erik Thunnissen	5
2	Prognostic value of proliferation, PD-L1 and nuclear size in patients with superior sulcus tumours treated with chemoradiotherapy and surgery 2021 ·Journal of Clinical Pathology ·Hans Blaauwgeers, Birgit I. Lissenberg‐Witte, Chris Dickhoff, Sylvia Duin, Erik Thunnissen	0
3	Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non–Small-Cell Lung Cancer 2020 ·Journal of Molecular Diagnostics ·Cleo Keppens, Jan H. von der Thüsen, Patrick Pauwels, Aleš Ryška, (unknown), Ed Schuuring, Keith Miller, Erik Thunnissen, Karen Zwaenepoel, Elisabeth Dequeker	7
4	Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment 2016 ·British Journal of Cancer ·JG Kuiper, Sayed M.S. Hashemi, Erik Thunnissen, Peter J.F. Snijders, Katrien Grünberg, Elisabeth Bloemena, Daoud Sie, Pieter E. Postmus, Daniëlle A.M. Heideman, Egbert F. Smit	56
5	Guidance for laboratories performing molecular pathology for cancer patients 2014 ·Journal of Clinical Pathology ·Ian A. Cree, Zandra C. Deans, Marjolijn J. L. Ligtenberg, Nicola Normanno, Anders Edsjö, Étienne Rouleau, Françesc Solé, Erik Thunnissen, Wim Timens, Ed Schuuring, Elisabeth Dequeker, Samuel Murray, Manfred Dietel, Patricia J.T.A. Groenen, J. Han van Krieken	154
6	CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids 2013 ·Clinical Cancer Research ·Dorian R.A. Swarts, Mieke E.R. Henfling, Leander Van Neste, Robert‐Jan van Suylen, Anne‐Marie C. Dingemans, Winand N.M. Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante, Wim Van Criekinge, Manon van Engeland, Frans C.�S. Ramaekers, Ernst‐Jan M. Speel	67
7	Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status 2012 ·Clinical Cancer Research ·Idris Bahce, Egbert F. Smit, Mark Lubberink, Astrid A.M. van der Veldt, Maqsood Yaqub, Albert D. Windhorst, Robert C. Schuit, Erik Thunnissen, Daniëlle A.M. Heideman, Pieter E. Postmus, Adriaan A. Lammertsma, N. Harry Hendrikse	92
8	Deletions of 11q22.3-q25 Are Associated with Atypical Lung Carcinoids and Poor Clinical Outcome 2011 ·American Journal Of Pathology ·Dorian R.A. Swarts, Sandra M.H. Claessen, Yvonne M.H. Versleijen‐Jonkers, Robert‐Jan van Suylen, Anne‐Marie C. Dingemans, Wouter W. de Herder, Ronald R. de Krijger, Egbert F. Smit, Erik Thunnissen, Cornelis A. Seldenrijk, Aryan Vink, Aurel Perren, Frans C. S. Ramaekers, Ernst‐Jan M. Speel	28
9	The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group 2011 ·Lung Cancer ·Erik Thunnissen, Keith M. Kerr, Felix Herth, Sylvie Lantuéjoul, Mauro Papotti, Robert C. Rintoul, Giulio Rossi, Birgit Guldhammer Skov, Birgit Weynand, Lukas Bubendorf, Katrien Grünberg, (unknown), Fernando López‐Ríos, Vincent Ninane, Włodzimierz Olszewski, Helmut Popper, (unknown), Philipp A. Schnabel, Luc Thiberville, Florian Laenger	167
10	Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene 2008 ·Cancer Research ·Narayan Shivapurkar, Victor Stastny, Naoki Okumura, Luc Girard, Yang Xie, Clemens Prinsen, Erik Thunnissen, Ignacio I. Wistuba, Bogdan Czerniak, Eugene P. Frenkel, Jack A. Roth, Triantafillos Liloglou, George Xinarianos, John K. Field, John D. Minna, Adi F. Gazdar	91
11	Differential Methylation of a Short CpG-Rich Sequence within Exon 1 of TCF21 Gene: A Promising Cancer Biomarker Assay 2008 ·Cancer Epidemiology Biomarkers & Prevention ·Narayan Shivapurkar, Victor Stastny, Yang Xie, Clemens Prinsen, Eugene P. Frenkel, Bogdan Czerniak, Erik Thunnissen, John D. Minna, Adi F. Gazdar	32
12	[Summary of the guideline 'Sentinel node biopsy in breast cancer.' Dutch Work Group 'Sentinel Node Biopsy for Breast Cancer']. 2000 ·PubMed ·(unknown), (unknown), Erik Thunnissen, (unknown)	20
13	Solitary intestinal fibromatosis as a cause of bile vomiting in a neonate 2000 ·Journal of Pediatric Surgery ·(unknown), C. E. Blanco, Erik Thunnissen, E. Heineman	1
14	Number and Proliferation of Clara Cells in Normal Human Airway Epithelium 1999 ·American Journal of Respiratory and Critical Care Medicine ·James E. Boers, Anton W. Ambergen, Erik Thunnissen	225
15	Number and Proliferation of Basal and Parabasal Cells in Normal Human Airway Epithelium 1998 ·American Journal of Respiratory and Critical Care Medicine ·James E. Boers, Anton W. Ambergen, Erik Thunnissen	194
16	In Vitro and In Vivo Modulation of Alpha- and Beta-Glucocorticoid-Receptor mRNA in Human Bronchial Epithelium 1997 ·American Journal of Respiratory and Critical Care Medicine ·S Korn, EF Wouters, Geertjan Wesseling, Jan‐Willem Arends, Erik Thunnissen	38
17	Interlaboratory comparison of DNA image analysis. 1996 ·PubMed ·Erik Thunnissen, Ian O. Ellis, Uta Jütting	11
18	P53 in Squamous Metaplasia: A Marker for Risk of Respiratory Tract Carcinoma 1996 ·American Journal of Respiratory and Critical Care Medicine ·James E. Boers, G P ten Velde, Erik Thunnissen	46
19	Number and Proliferation of Neuroendocrine Cells in Normal Human Airway Epithelium 1996 ·American Journal of Respiratory and Critical Care Medicine ·James E. Boers, (unknown), J Koudstaal, Jan Willem Arends, Erik Thunnissen	89
20	Characterization of the constitutively expressed nitric-oxide synthase in human respiratory epithelium in-vivo 1995 ·The FASEB Journal ·(unknown), (unknown), Erik Thunnissen, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact